PlainRecalls

Orient Pharma Co., Ltd. Yunlin Plant

Compiled from official public sources by the publisher.

2 recalls on record · Latest: Jul 9, 2025

Subscribe to new Orient Pharma Co., Ltd. Yun… recalls (RSS)

Agency notice ledger

Federal filing book Orient Pharma Co., Ltd. Yun… LIGHT-BOOK · SINGLE-AGENCY

#5,493 of 14,151 · 2 notices · 0.002% archive

  • BOOK 2 notices
  • RANK #5,493 of 14,151
  • SHARE 0.002% archive
  • AGENCY FDA Drug (2)
  • CAT drugs
  • CATS 1 category
  • LATEST Jul 9, 2025
  • PHOTO 3M Company

Nearest notice-volume peer: 3M Company (0 notice gap)

Orient Pharma Co., Ltd. Yunlin Plant accounts for about 0.002% of the 104,423-notice archive on 2 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Orient Pharma Co., Ltd. Yun… sits among 14,151 recalling firms

Orient Pharma Co., Ltd. Yunlin Plant ranks 5,493rd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Orient Pharma Co., Ltd. Yun… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

2 5493rd of 14151 higher than 8,037 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-15

Orient Pharma Co., Ltd. Yun… in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Orient Pharma Co., Ltd. Yunlin Plant holds about 0.002% of archive notices alongside 2 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Jul 9, 2025

Pitavastatin Tablets, 1 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiwan, NDC 0480-3631-98.
FDA Drug Low Jul 9, 2025

Pitavastatin Tablets, 2 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiwan, NDC 0480-3632-98.

Orient Pharma Co., Ltd. Yun… is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Orient Pharma Co., Ltd. Yun…? ▼
PlainRecalls indexes 2 distinct federal recall events naming Orient Pharma Co., Ltd. Yunlin Plant, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Orient Pharma Co., Ltd. Yun… sit among other recalling firms? ▼
Orient Pharma Co., Ltd. Yunlin Plant ranks #5,493 of 14,151 by distinct recall-event count among 14,151 firms in this archive (57th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Orient Pharma Co., Ltd. Yun…'s notices? ▼
FDA Drug accounts for 2 of this firm's 2 indexed notices.
What product category dominates Orient Pharma Co., Ltd. Yun…'s filing book? ▼
Filings for Orient Pharma Co., Ltd. Yunlin Plant span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Orient Pharma Co., Ltd. Yunlin Plant: 2 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Orient Pharma Co., Ltd. Yunlin Plant; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026